Your browser doesn't support javascript.
loading
Research in revealing the effects on Cuscuta chinensis to diarrhea type irritable bowel syndrome based on network pharmacology and molecular docking potential mechanism.
Yang, Shili; Liu, Huaiquan; Li, Kewei; Chen, Bo; Tang, Yi; Li, Jie; Wang, Dan; Zhang, Xinyan.
Affiliation
  • Yang S; Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
  • Liu H; Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
  • Li K; Sichuan College of Traditional Chinese Medicine, Mianyang, Sichuan, China.
  • Chen B; Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
  • Tang Y; Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
  • Li J; Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
  • Wang D; Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
  • Zhang X; Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Medicine (Baltimore) ; 103(19): e38113, 2024 May 10.
Article in En | MEDLINE | ID: mdl-38728495
ABSTRACT
To explore the potential mechanism in Cuscuta sinensis on diarrhea-type irritable bowel syndrome using network pharmacology and molecular docking techniques. First, the active components and related targets of Cuscuta were found setting oral utilization >30% and drug-like properties greater than or equal to 0.18 as filter information from TCMSP database. The targets of diarrheal irritable bowel syndrome were compiled by searching DrugBank, GeneCards, OMIM, PharmGkb, and TTD databases. The intersections of drugs and targets related to the disease were taken for gene ontology enrichment and Kyoto encyclopedia of genes and genomes enrichment analyses, to elucidate the potential molecular mechanisms and pathway information of Cuscuta sinensis for the treatment of diarrheal irritable bowel syndrome. The protein-protein interaction network was constructed by using the STRING database and visualized with Cytoscape_v3.10.0 software to find the protein-protein interaction network core At last, molecular docking was performed to validate the combination of active compounds with the core target. The target information of Cuscuta and diarrhea-type irritable bowel syndrome was compiled, which can be resulted in 11 active compounds such as quercetin, kaempferol, isorhamnetin, ß-sitosterol, and another 17 core targets such as TP53, IL6, AKT1, IL1B, TNF, EGFR, etc, whose Kyoto encyclopedia of genes and genomes was enriched in the pathways of lipids and atherosclerosis, chemical carcinogenesis-receptor activation, PI3K-Akt signaling pathway, and fluid shear stress and atherosclerosis, etc. Docking demonstrated that the core targets and the active compounds were able to be better combined. Cuscuta chinensis may exert preventive effects on diarrhea-type irritable bowel syndrome by reducing intestinal inflammation, protecting intestinal mucosa, and playing an important role in antioxidant response through multi-targets and multi-pathways.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cuscuta / Irritable Bowel Syndrome / Diarrhea / Protein Interaction Maps / Molecular Docking Simulation / Network Pharmacology Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2024 Document type: Article Affiliation country: China Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cuscuta / Irritable Bowel Syndrome / Diarrhea / Protein Interaction Maps / Molecular Docking Simulation / Network Pharmacology Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2024 Document type: Article Affiliation country: China Country of publication: Estados Unidos